Geode Capital Management’s Impel Pharmaceuticals Inc. Common Stock IMPL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-172,218
| Closed | -$74.1K | – | 4727 |
|
|
2023
Q3 | $74.1K | Buy |
172,218
+17,258
| +11% | +$7.42K | ﹤0.01% | 4324 |
|
|
2023
Q2 | $197K | Buy |
154,960
+570
| +0.4% | +$724 | ﹤0.01% | 4046 |
|
|
2023
Q1 | $216K | Buy |
154,390
+152
| +0.1% | +$213 | ﹤0.01% | 4011 |
|
|
2022
Q4 | $578K | Buy |
154,238
+5,592
| +4% | +$21K | ﹤0.01% | 3597 |
|
|
2022
Q3 | $723K | Buy |
148,646
+33,461
| +29% | +$163K | ﹤0.01% | 3550 |
|
|
2022
Q2 | $1.07M | Sell |
115,185
-46,604
| -29% | -$434K | ﹤0.01% | 3389 |
|
|
2022
Q1 | $1.03M | Buy |
161,789
+32,989
| +26% | +$210K | ﹤0.01% | 3610 |
|
|
2021
Q4 | $1.11M | Buy |
128,800
+10,884
| +9% | +$93.9K | ﹤0.01% | 3670 |
|
|
2021
Q3 | $1.44M | Buy |
117,916
+66,974
| +131% | +$816K | ﹤0.01% | 3507 |
|
|
2021
Q2 | $450K | Buy |
+50,942
| New | +$450K | ﹤0.01% | 3990 |
|